These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 32738228

  • 21. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
    Hedayatfar A, Hosseini SM, Karimi N, Falavarjani KG, Badie N, Zameni M, Soheilian M.
    Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
    [Abstract] [Full Text] [Related]

  • 22. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.
    da Silva FT, Hirata CE, Sakata VM, Olivalves E, Preti R, Pimentel SL, Gomes A, Takahashi WY, Costa RA, Yamamoto JH.
    BMC Ophthalmol; 2012 Aug 13; 12():40. PubMed ID: 22889440
    [Abstract] [Full Text] [Related]

  • 23. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.
    Herbort CP, Abu El Asrar AM, Yamamoto JH, Pavésio CE, Gupta V, Khairallah M, Tugal-Tutkun I, Soheilian M, Takeuchi M, Papadia M.
    Int Ophthalmol; 2017 Dec 13; 37(6):1383-1395. PubMed ID: 27844182
    [Abstract] [Full Text] [Related]

  • 24. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease.
    Herbort CP, Abu El Asrar AM, Takeuchi M, Pavésio CE, Couto C, Hedayatfar A, Maruyama K, Rao X, Silpa-Archa S, Somkijrungroj T.
    Int Ophthalmol; 2019 Jun 13; 39(6):1419-1425. PubMed ID: 29948499
    [Abstract] [Full Text] [Related]

  • 25. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P, Liu X, Zhou H, Guo W, Zhou C, Kijlstra A.
    Clin Exp Ophthalmol; 2011 Jun 13; 39(7):639-47. PubMed ID: 22452682
    [Abstract] [Full Text] [Related]

  • 26. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H, Rao NA.
    Am J Ophthalmol; 2001 May 13; 131(5):607-14. PubMed ID: 11336935
    [Abstract] [Full Text] [Related]

  • 27. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
    Kryshtalskyj MT, Roy M.
    Ocul Immunol Inflamm; 2022 May 19; 30(4):894-900. PubMed ID: 33621146
    [Abstract] [Full Text] [Related]

  • 28. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, Nishida K.
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul 19; 250(7):1089-95. PubMed ID: 22240936
    [Abstract] [Full Text] [Related]

  • 29. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
    Bacsal K, Wen DS, Chee SP.
    Am J Ophthalmol; 2008 Mar 19; 145(3):480-486. PubMed ID: 18191100
    [Abstract] [Full Text] [Related]

  • 30. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM.
    Acta Ophthalmol; 2016 Sep 19; 94(6):573-8. PubMed ID: 26823203
    [Abstract] [Full Text] [Related]

  • 31. Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Alotaibi MD, Gikandi PW, Stefánsson E.
    Acta Ophthalmol; 2021 Feb 19; 99(1):75-82. PubMed ID: 32592327
    [Abstract] [Full Text] [Related]

  • 32. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
    Alromaih AZ, Almater AI, Albloushi AF, Alkheraiji NF, Abu El-Asrar AM.
    Int Ophthalmol; 2023 Jan 19; 43(1):185-195. PubMed ID: 35945413
    [Abstract] [Full Text] [Related]

  • 33. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
    Keino H, Goto H, Usui M.
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct 19; 240(10):878-82. PubMed ID: 12397437
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
    Takayama K, Obata H, Takeuchi M.
    Ocul Immunol Inflamm; 2020 Apr 02; 28(3):509-512. PubMed ID: 31268769
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.
    Bolletta E, Gozzi F, Mastrofilippo V, Pipitone N, De Simone L, Croci S, Invernizzi A, Adani C, Iannetta D, Coassin M, Fontana L, Salvarani C, Cimino L.
    Ocul Immunol Inflamm; 2022 Aug 02; 30(6):1303-1308. PubMed ID: 33793383
    [Abstract] [Full Text] [Related]

  • 36. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
    Lee EK, Lee SY, Yu HG.
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar 02; 253(3):359-68. PubMed ID: 25017008
    [Abstract] [Full Text] [Related]

  • 37. Vogt-Koyanagi-Harada disease in Hispanic patients.
    Sukavatcharin S, Tsai JH, Rao NA.
    Int Ophthalmol; 2007 Mar 02; 27(2-3):143-8. PubMed ID: 17380271
    [Abstract] [Full Text] [Related]

  • 38. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A, Kusuhara S, Awano H, Nagase H, Matsumiya W, Nakamura M.
    BMC Ophthalmol; 2019 Aug 13; 19(1):179. PubMed ID: 31409322
    [Abstract] [Full Text] [Related]

  • 39. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I, Ahmed M, Foster CS.
    Ocul Immunol Inflamm; 2006 Apr 13; 14(2):87-90. PubMed ID: 16597537
    [Abstract] [Full Text] [Related]

  • 40. Vogt-Koyanagi-Harada disease.
    O'Keefe GA, Rao NA.
    Surv Ophthalmol; 2017 Apr 13; 62(1):1-25. PubMed ID: 27241814
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.